Bcg

BCG (Bacillus Calmette-Guérin) is a bacterial preparation used primarily for intravesical therapy. It is often associated with bladder cancer treatment and immune system modulation.

BCG is commonly used in the treatment of bladder cancer, particularly for non-muscle-invasive bladder cancer. It works by stimulating the immune system to target cancer cells. BCG therapy is administered directly into the bladder, where it helps to reduce the recurrence of cancerous cells.

Common effects of BCG therapy may include flu-like symptoms such as fever, chills, and fatigue. Some individuals may also experience bladder irritation, leading to frequency, urgency, or discomfort during urination. These effects are generally temporary and subside as the body adjusts to the treatment.

BCG therapy should be handled with care to avoid contamination. It is important to follow proper hygiene practices to prevent accidental exposure. Individuals with active urinary tract infections or certain immune system disorders may need to avoid BCG therapy. Always consult a healthcare provider for personalized advice.

BCG therapy may interact with certain medications that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking. Alcohol and other substances that suppress the immune system should be avoided during BCG therapy to ensure its effectiveness.